Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Wilke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Medicine Insights. Pediatrics|May 4, 2013
Invasive fungal infections in infants-focus on anidulafunginMichael H Wilke
European Journal of Medical Research|December 18, 2010
Multiresistant bacteria and current therapy - the economical side of the storyMichael H Wilke
European Journal of Medical Research|December 18, 2010
Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approachMichael H Wilke, R Grube
Australian Health Review : a Publication of the Australian Hospital Association|July 26, 2002
Detection and documentation of DRG-relevant comorbidities using laboratory testsMichael H Wilke, Mike Schenker, Georg Hoffmann
Clinical Laboratory|June 20, 2002
Impact of laboratory testing on DRG coding and reimbursement--results of a data base researchGeorg E Hoffman, Michael Schenker, Michael H Wilke
Infection|May 31, 2022
Carbapenem-resistant gram-negative bacteria in Germany: incidence and distribution among specific infections and mortality: an epidemiological analysis using real-world dataMichael H Wilke, Birgit Preisendörfer, Anna Seiffert, et al.
Clinical Laboratory|October 16, 2004
The significance of laboratory testing for the German diagnosis-related group system--the systematic evaluation of comorbidities of relevance to case reimbursement and continued development of the DRG Watchdog softwareGeorg E Hoffmann, Mike Schenker, Markus Kammann, et al.
GMS Infectious Diseases|January 24, 2019
Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin - a retrospective analysis of medical charts and re-imbursement data of real-life patient populationsMichael H Wilke, Karsten Becker, Sebastian Kloss, et al.
Zeitschrift Fur Gastroenterologie|September 14, 2017
[Cost assessment for endoscopic procedures in the German diagnosis-related-group (DRG) system - 5 year cost data analysis of the German Society of Gastroenterology project]Markus Rathmayer, Wolfgang Heinlein, Claudia Reiß, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Medicine Insights. Pediatrics|May 4, 2013
Invasive fungal infections in infants-focus on anidulafunginMichael H Wilke
European Journal of Medical Research|December 18, 2010
Multiresistant bacteria and current therapy - the economical side of the storyMichael H Wilke
European Journal of Medical Research|December 18, 2010
Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approachMichael H Wilke, R Grube
Australian Health Review : a Publication of the Australian Hospital Association|July 26, 2002
Detection and documentation of DRG-relevant comorbidities using laboratory testsMichael H Wilke, Mike Schenker, Georg Hoffmann
Clinical Laboratory|June 20, 2002
Impact of laboratory testing on DRG coding and reimbursement--results of a data base researchGeorg E Hoffman, Michael Schenker, Michael H Wilke
Infection|May 31, 2022
Carbapenem-resistant gram-negative bacteria in Germany: incidence and distribution among specific infections and mortality: an epidemiological analysis using real-world dataMichael H Wilke, Birgit Preisendörfer, Anna Seiffert, et al.
Clinical Laboratory|October 16, 2004
The significance of laboratory testing for the German diagnosis-related group system--the systematic evaluation of comorbidities of relevance to case reimbursement and continued development of the DRG Watchdog softwareGeorg E Hoffmann, Mike Schenker, Markus Kammann, et al.
GMS Infectious Diseases|January 24, 2019
Treatment of MRSA pneumonia: Clinical and economic comparison of linezolid vs. vancomycin - a retrospective analysis of medical charts and re-imbursement data of real-life patient populationsMichael H Wilke, Karsten Becker, Sebastian Kloss, et al.
Zeitschrift Fur Gastroenterologie|September 14, 2017
[Cost assessment for endoscopic procedures in the German diagnosis-related-group (DRG) system - 5 year cost data analysis of the German Society of Gastroenterology project]Markus Rathmayer, Wolfgang Heinlein, Claudia Reiß, et al.
Pageof 1